A Phase I and Pharmacokinetic Study of Selenomethionine With Fixed Dose Irinotecan in Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 03 Feb 2012
At a glance
- Drugs Selenium (Primary) ; Irinotecan
- Indications Solid tumours
- Focus Adverse reactions
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Nov 2007 Status change from recruiting to in progress.
- 22 Aug 2005 New trial record.